IL22 and Other metabolic disease: In contrast to IL-22-Fc, anti-FGFR1 antibody failed to stimulate the wound healing process in db/db mice despite lowering serum glucose, suggesting that improvement of metabolic disorders alone is not sufficient to promote wound healing in this model (Fig 3B–3F).